Takeda Pharma is a global pharmaceutical company that strives to improve the health and wellbeing of people worldwide. They develop and commercialize innovative medicines, offer a related portfolio of products and services, and utilize state-of-the-art technologies to advance its research and development initiatives.
Founded in 1781 in Osaka, Japan
Became a dedicated pharmaceutical company in 1948 and expanded globally in the 1970s
Acquired Millennium Pharmaceuticals in 2008
Completed the acquisition of Shire in 2019, becoming one of the largest pharmaceutical companies in the world.
Pfizer is a global pharmaceutical corporation that develops and produces medicines and vaccines. The company's products are sold in more than 190 countries.
Novartis is a multinational pharmaceutical company based in Switzerland. It develops and manufactures drugs, vaccines, and diagnostic tools.
Roche is a global pharmaceutical corporation that develops and produces drugs and diagnostic tests. The company has operations in more than 100 countries.
Used to treat ulcerative colitis and Crohn's disease, Entyvio is an integrin receptor antagonist that works by reducing inflammation in the digestive tract.
Brilinta is an oral antiplatelet medication used to prevent blood clots in patients with acute coronary syndrome. It works by preventing platelets from sticking together and forming clots.
Trintellix is an antidepressant medication used to treat major depressive disorder. It works by increasing the levels of serotonin in the brain.
Takeda Pharma is a global pharmaceutical company that develops and commercializes innovative medicines to improve the health and wellbeing of people worldwide.
Some of Takeda Pharma's main products include Entyvio, Brilinta, and Trintellix.
Entyvio is used to treat ulcerative colitis and Crohn's disease by reducing inflammation in the digestive tract.
Takeda Pharma was founded in Osaka, Japan in 1781, became a dedicated pharmaceutical company in 1948, expanded globally in the 1970s, acquired Millennium Pharmaceuticals in 2008, and completed the acquisition of Shire in 2019.
Takeda Pharma's competitors include Pfizer, Novartis, and Roche, among others.